The Role of the Hepatology Nurse in the Difficult-To-Treat Hepatitis C Population

by Jo-Ann Ford, Cindy Cheong-Lee
Published 2007-01-01

Patients' Perspectives on Early Liver Transplantation in Alcohol‐Related Liver Disease

by Eric Wong, Paul D. Mullins, Jean‐Philippe Wallach, Eric M. Yoshida, Sigfried R. Erb, Jo‐Ann Ford, Charles H. Scudamore, Vladimir Marquez
Published 2019-08-01

Seroprevalences of Hepatitis B Virus and Hepatitis C Virus among Participants of an Asian Health Fair in the Lower Mainland, British Columbia

by Stephen Ip, Jo-Ann Ford, Kirby Lau, Vladimir Marquez, Marisa Guan, Carolyn Klassen, Jessica Chan, WC Peter Kwan, Mel Krajden, Eric M Yoshida
Published 2015-01-01

First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder

by Nawal Al Nahdi, Jo-Ann Ford, Erica D. Greanya, Jo-Ann Harrigan, Irene Tse, Urs P. Steinbrecher, Siegfried R. Erb, Eric M. Yoshida
Published 2013-01-01

Hepatitis B Awareness and Knowledge in Asian Communities in British Columbia

by Alan Hoi Lun Yau, Jo-Ann Ford, Peter Wing Cheung Kwan, Jessica Chan, Queenie Choo, Tim K. Lee, Willie Kwong, Alan Huang, Eric Yoshida
Published 2016-01-01

Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism

by Ramesh Saeedi, Ali Mojebi-Mogharar, Supna K. Sandhu, Joshua A. Dubland, Jo-Ann Ford, Masoud Yousefi, Morris Pudek, Daniel T. Holmes, Siegfried R. Erb, Wing C. Peter Kwan, David L Kendler, Eric M. Yoshida
Published 2017-03-01

Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment

by Jennifer J. Lin, Catrina M. Loucks, Jessica N. Trueman, Britt I. Drögemöller, Galen E.B. Wright, Eric M. Yoshida, Jo-Ann Ford, Samuel S. Lee, Richard B. Kim, Bandar Al-Judaibi, Ute I. Schwarz, Alnoor Ramji, Edward Tam, Colin J. Ross, Bruce C. Carleton
Published 2021-11-01